The alfapump® system is currently not approved in the United States or Canada. In the United States and Canada, the alfapump® system is currently under clinical investigation (POSEIDON Study) and is being studied in adult patients with refractory or recurrent ascites due to cirrhosis. DSR® therapy is still in development and it should be noted that any statements regarding safety and efficacy arise from ongoing pre-clinical and clinical investigations which have yet to be completed. There is no link between the DSR® therapy and ongoing investigations with the alfapump® system in Europe, the United States or Canada.

Where to find alfapump®

If your doctor believes that the alfapump® system is a suitable treatment option for your condition, we recommend that you contact one of the centres in Europe that is using the alfapump system.

Physicians at these centres will be able to examine you and advise both you and your relatives on the best course of action.

For more information on the alfapump® system, please visit our dedicated website